Q . What role and responsibilities does a “Product strategy lead” play within oncology at a Major pharmaceutical company such as Novartis?
As a Product Strategy Lead within oncology at a big pharma company like Novartis, your role and responsibilities would typically involve strategic planning and execution related to oncology products.
Here are some key aspects of your role:
1. Product Portfolio Strategy: You would contribute to the development and implementation of the overall product portfolio strategy for oncology. This would include evaluating the competitive landscape, assessing market trends, and identifying opportunities for new product development or portfolio expansion.
2. Market Analysis: You would conduct comprehensive market analysis to understand the needs of patients, physicians, and other stakeholders in the oncology space. This involves gathering and analyzing data on disease prevalence, treatment options, reimbursement dynamics, and pricing trends to inform strategic decision-making.
3. Competitive Intelligence: You would monitor and analyze the activities of competitors in the oncology market, including their product pipelines, clinical trials, and market positioning. This information helps to identify potential threats and opportunities and guides the development of effective strategies.
4. Lifecycle Management: You would play a key role in managing the lifecycle of oncology products, from early-stage development to commercialization and beyond. This involves collaborating with cross-functional teams, such as R&D, medical affairs, marketing, and commercial teams, to ensure alignment and maximize the product's potential.
5. Strategic Planning: You would contribute to the development of long-term strategic plans for the oncology business unit, taking into account factors such as market dynamics, regulatory landscape, and emerging technologies. These plans would outline the objectives, initiatives, and resource allocation required to achieve business goals.
6. Launch Strategy: You would be involved in developing launch strategies for new oncology products, considering aspects such as market positioning, pricing, market access, and promotional activities. Collaborating with marketing and commercial teams, you would help create compelling value propositions and ensure effective communication of product benefits.
7. Cross-functional Collaboration: As a Product Strategy Lead, you would collaborate closely with various internal stakeholders, including R&D, clinical development, regulatory affairs, medical affairs, commercial, and finance teams. This collaboration ensures alignment and effective execution of product strategies across functions.
8. External Engagement: You may also engage with external stakeholders, including healthcare professionals, patient advocacy groups, and key opinion leaders in the oncology field. This helps to gain insights, gather feedback, and build relationships that support product strategy and development.
Overall, as a Product Strategy Lead within oncology at a big pharma company like Novartis, your responsibilities would revolve around shaping the strategic direction of oncology products, ensuring their successful commercialization, and maximizing their impact on patient care.
- “Damian, Great to connect Marilina, love your passion”
- Marilina, Back at you! So much to do, as we embark on this journey together”
CEO - ex novartis
Hiring current novartis, BMS, Celgene etc
Connecting with multiple current novartis
Novartis itself posting about tackling breast cancer
10 + external clinical advisors to guide design, strategy, and path to commercialisation
USA Product strategy lead “Embark on this journey together”
USA centric valuation on breast cancer
DCB “it will all make sense in July/Aug”
Meh, could be nothing..
You’d have to be very game to be letting go of shares right now.
Good luck to those that are, i think you’ll need it when we go into a trading halt.
General Comments / Chat, page-8022
-
- There are more pages in this discussion • 3,093 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |